Market Cap | ₹26,376Cr |
ROE | 15.32% |
P/E Ratio(TTM) | 35.44 |
EPS(TTM) | 39.27 |
P/B Ratio | 5.93 |
Dividend Yield | 0.22% |
Industry P/E | 34.34 |
Book Value | 234.62 |
Debt to Equity | 0.23 |
Face Value | 10 |
Parent Organisation | Emcure Pharmaceuticals |
NSE Symbol | EMCURE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.61 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.39 | ||
Wockhardt | NA (0.00%) | -188.59 | ||
Concord Biotech | NA (0.00%) | 49.39 |